Cathie Wood is beating the market again so far in 2023, and that leaves growth investors wondering if she can recapture her 2020 performance in a bottle. Her style of investing in disruptors and aggressive growth is paying off lately, but she still has a long way to go to overcome the steep losses her Ark Invest family of exchange-traded funds suffered in 2021 and 2022.

Ark puts out daily transaction reports, so we know what Wood is buying and selling. She kicked off the new trading week by adding to her positions in Tesla (NASDAQ: TSLA), Intellia Therapeutics (NASDAQ: NTLA), and Teladoc Health (NYSE: TDOC) yesterday. Let's take a closer look.

As any fan of fast cars knows, starting lines matter. Tesla bears think they're winning with the stock down 65% since hitting all-time highs in late 2021. Bulls know that they have the long track on lock, with the stock up 472% over the past five years and an 83-bagger since its IPO. Bulls can also celebrate that the shares are up by more than 40% since bottoming out three weeks ago.

Continue reading

Source Fool.com